ADAM AUFDERHEIDE, MD
Ophthalmology Physician · MEDFORD, OR
Individual Active NPI 1982915344
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 834 | 43,560 | $8,710,867 | $3,960,649 | $3,118,070 |
| 2023 | 901 | 26,215 | $6,970,711 | $3,664,745 | $2,881,467 |
| 2022 | 953 | 12,626 | $6,267,162 | $3,421,720 | $2,684,384 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J2777 | Injection, faricimab-svoa, 0.1 mg | 28,860 | $34 | $27 |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 5,970 | $147 | $117 |
| 92134 | Imaging of retina | 2,219 | $41 | $30 |
| J0178 | Injection, aflibercept, 1 mg | 1,700 | $821 | $653 |
| 67028 | Injection of drug into eye | 1,610 | $130 | $97 |
| 92012 | Established patient problem focused exam of visual system | 898 | $91 | $66 |
| 92014 | Established patient complete exam of visual system | 454 | $128 | $83 |
| J2778 | Injection, ranibizumab, 0.1 mg | 294 | $160 | $127 |
| J7999 | Compounded drug, not otherwise classified | 153 | $93 | $73 |
| 92250 | Photography of the retina | 99 | $38 | $27 |
| 92201 | Extended exam of the back part of the eye with retinal drawing | 98 | $25 | $17 |
| 92004 | New patient complete exam of visual system | 87 | $152 | $96 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Ophthalmology Physician | 207W00000X | ✓ | MD176895 | OR |
| Ophthalmology Physician | 207W00000X | 51281 | TN | |
| Ophthalmology Physician | 207W00000X | 9407515 | KS |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Ophthalmology Physician providers in Oregon
- NPI 1265729081
- NPI 1609913219
- NPI 1770112476
- NPI 1457518771
- NPI 1811962400
- NPI 1528052271
- NPI 1922089689
- NPI 1609944347
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.